Talha Badar/X
Dec 10, 2024, 23:59
Talha Badar: PrECOG 0905 Gilt vs Mido in ND FLT3m AML
Talha Badar, Hematology/Oncology specialist in Mayo Clinic, shared a post on X:
“ASH24.
PrECOG 0905 Gilt vs Mido in ND FLT3m AML at ECOG-ACRIN Cancer Research Group.
PE: mutation MRD -ve composite CR.
Results: cCR was higher with Gilt (85.6 vs 72.4), however cCR with molecular MRD was NS post induction.
Inference: molecular MRD at later time point might worth exploring.”
More posts featuring Talha Badar.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 10, 2024, 23:59
Dec 10, 2024, 23:22
Dec 10, 2024, 19:35
Dec 10, 2024, 19:22
Dec 10, 2024, 19:16
Dec 10, 2024, 19:12
Dec 10, 2024, 19:08
Dec 10, 2024, 19:04
Dec 10, 2024, 18:58